Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expression of Prostate Specific Membrane Antigen (PSMA) in Soft Tissue Sarcomas and Urothelial Cell Carcinomas: Implications for Tumour-specific Molecular Imaging and Treatment?

NCT05522257 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT05522257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05522257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expression of Prostate Specific Membrane Antigen (PSMA) in Soft Tissue Sarcomas and Urothelial Cell Carcinomas: Implications for Tumour-specific Molecular Imaging and Treatment?
Lead sponsor
Leiden University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2022
Completion date
July 22, 2024
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma,soft tissue, urothelial carcinoma